<DOC>
	<DOC>NCT02158572</DOC>
	<brief_summary>Study of the efficacy of a contraceptive patch in 2100 healthy women for up to one year.</brief_summary>
	<brief_title>Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System</brief_title>
	<detailed_description>AG200-15 is used in a 4-week (28-day) treatment cycle: a patch is applied and replaced every 7 days for 3 consecutive weeks, followed by a 1-week "patch-free" period.</detailed_description>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy, sexually active woman at risk for pregnancy seeking to use hormonal contraception for at least 1 year Ability to demonstrate willingness to participate and adhere to study protocol Known or suspected pregnancy Lactating women Anticipates use of condoms or any other form of backup contraception during the study History of dermal sensitivity to medicated patches (nicotine) or to bandages, surgical tape, etc. Has a contraindication to combined estrogenprogestin contraceptive use Any disease that may worsen under hormonal treatment (cardiovascular, liver, metabolic) Smoker who is 35 years old or over</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>prevention of pregnancy</keyword>
</DOC>